PKFT
Company Details
Linkedin ID:
pt-kalbe-farma
Website:
Employees number:
12,334
Number of followers:
1,078,617
NAICS:
3254
Industry Type:
Homepage:
kalbe.co.id
IP Addresses:
0
Company ID:
PT _3312386
Scan Status:
In-progress
PT Kalbe Farma, Tbk Company CyberSecurity Posture
kalbe.co.id
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.
PT Kalbe Farma, Tbk A.I CyberSecurity Scoring
PKFT Risk Score (AI oriented)Between 750 and 799
PKFT
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
PKFT Global Score (TPRM)XXXX
PKFT
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
PKFT Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
PKFT Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for PKFT
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for PT Kalbe Farma, Tbk in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for PT Kalbe Farma, Tbk in 2025.
Incident Types PKFT vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for PT Kalbe Farma, Tbk in 2025.
Incident History — PKFT (X = Date, Y = Severity)
PKFT cyber incidents detection timeline including parent company and subsidiaries
PKFT Company Subsidiaries
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.
Loading...
PKFT Similar Companies
At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to p
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
Lupin
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Tr
MENARINI Group
The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic
Fresenius Kabi
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa
The Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving ac
.png)
PKFT CyberSecurity News
September 20, 2024 07:00 AM
HR Gathering 2024: The Importance of Cybersecurity Awareness and Data Governance for Organisations
Monash University, Indonesia hosted HR Gathering event, drawing approximately 70 professionals from diverse sectors on Thursday, 19 September 2024.
April 24, 2024 07:00 AM
Kalbe Continues Collaboration with Monash University, Indonesia, Enhancing Management Expertise
PT Kalbe Farma Tbk (Kalbe) is continuing its collaboration with Monash University, Indonesia. This collaboration aims to enhance global business competencies.
May 12, 2023 07:00 AM
Monash University, Indonesia Working With Kalbe To Strengthen Leaders Capacity
Monash University, Indonesia signed a memorandum of understanding (MoU) with PT Kalbe Farma Tbk (Kalbe). This collaboration is a testament of Monash University...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
PKFT CyberSecurity History Information
Official Website of PT Kalbe Farma, Tbk
The official website of PT Kalbe Farma, Tbk is http://www.kalbe.co.id/.
PT Kalbe Farma, Tbk’s AI-Generated Cybersecurity Score
According to Rankiteo, PT Kalbe Farma, Tbk’s AI-generated cybersecurity score is 794, reflecting their Fair security posture.
How many security badges does PT Kalbe Farma, Tbk’ have ?
According to Rankiteo, PT Kalbe Farma, Tbk currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does PT Kalbe Farma, Tbk have SOC 2 Type 1 certification ?
According to Rankiteo, PT Kalbe Farma, Tbk is not certified under SOC 2 Type 1.
Does PT Kalbe Farma, Tbk have SOC 2 Type 2 certification ?
According to Rankiteo, PT Kalbe Farma, Tbk does not hold a SOC 2 Type 2 certification.
Does PT Kalbe Farma, Tbk comply with GDPR ?
According to Rankiteo, PT Kalbe Farma, Tbk is not listed as GDPR compliant.
Does PT Kalbe Farma, Tbk have PCI DSS certification ?
According to Rankiteo, PT Kalbe Farma, Tbk does not currently maintain PCI DSS compliance.
Does PT Kalbe Farma, Tbk comply with HIPAA ?
According to Rankiteo, PT Kalbe Farma, Tbk is not compliant with HIPAA regulations.
Does PT Kalbe Farma, Tbk have ISO 27001 certification ?
According to Rankiteo,PT Kalbe Farma, Tbk is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk employs approximately 12,334 people worldwide.
Subsidiaries Owned by PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk presently has no subsidiaries across any sectors.
PT Kalbe Farma, Tbk’s LinkedIn Followers
PT Kalbe Farma, Tbk’s official LinkedIn profile has approximately 1,078,617 followers.
NAICS Classification of PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
PT Kalbe Farma, Tbk’s Presence on Crunchbase
No, PT Kalbe Farma, Tbk does not have a profile on Crunchbase.
PT Kalbe Farma, Tbk’s Presence on LinkedIn
Yes, PT Kalbe Farma, Tbk maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/pt-kalbe-farma.
Cybersecurity Incidents Involving PT Kalbe Farma, Tbk
As of December 13, 2025, Rankiteo reports that PT Kalbe Farma, Tbk has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
PT Kalbe Farma, Tbk has an estimated 5,425 peer or competitor companies worldwide.
PT Kalbe Farma, Tbk CyberSecurity History Information
How many cyber incidents has PT Kalbe Farma, Tbk faced ?
Total Incidents: According to Rankiteo, PT Kalbe Farma, Tbk has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at PT Kalbe Farma, Tbk ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, there is no handler for JSON parsing errors; SyntaxError from express.json() includes user input in the error message, which gets reflected in responses. User input (including HTML/JavaScript) can be exposed in error responses, creating an XSS risk if Content-Type isn't strictly enforced. This issue does not have a fix at the time of publication.
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when creating prompts, JSON requests are sent to define and modify the prompts via PATCH endpoint for prompt groups (/api/prompts/groups/:groupId). However, the request bodies are not sufficiently validated for proper input, enabling users to modify prompts in a way that was not intended as part of the front end system. The patchPromptGroup function passes req.body directly to updatePromptGroup() without filtering sensitive fields. This issue is fixed in version 0.8.1.
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when a user posts a question, the iconURL parameter of the POST request can be modified by an attacker. The malicious code is then stored in the chat which can then be shared to other users. When sharing chats with a potentially malicious “tracker”, resources loaded can lead to loss of privacy for users who view the chat link that is sent to them. This issue is fixed in version 0.8.1.
Risk Information
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
MaxKB is an open-source AI assistant for enterprise. Versions 2.3.1 and below have improper file permissions which allow attackers to overwrite the built-in dynamic linker and other critical files, potentially resulting in privilege escalation. This issue is fixed in version 2.4.0.
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Description
MaxKB is an open-source AI assistant for enterprise. In versions 2.3.1 and below, the tool module allows an attacker to escape the sandbox environment and escalate privileges under certain concurrent conditions. This issue is fixed in version 2.4.0.
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=pt-kalbe-farma' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
